Global Health Financing at the Tipping Point
Crisis or Catalyst for Change?
Date
Monday, 13th October
Time
09:00-10:30 CEST
07:00-08:30 UTC
Room
Pavillon
About the session
To navigate funding shortfalls, international health institutions are already implementing or have initiated reform and restructuring processes to contain costs and (re-)define priorities. Various reform proposals are being considered ranging from (re-)focusing on core mandates and functions, streamlining mandates, or increasing efficiencies to more profound changes such as merging institutions or even sunsetting certain areas.
The session will explore how institutions are adapting to shrinking financial spaces and aims to foster dialogue around sustainable strategies to navigate the crisis. How are GH institutions reacting? What role does “innovative financing” play? Is there a “power shift” in GH financing? Does the shift in financing present an opportunity for Low- and Middle-Income Countries (LMICs) to build self-sustaining, locally led systems? In this session, we will discuss reform pathways to a new GH financing ecosystem.
Chair(s) / Moderator(s)
Speakers
Kalipso Chalkidou
World Health Organization (WHO)
Department of Performance, Financing and Delivery (PFD) | Director
Switzerland
Ruth Lawson
Foreign, Commonwealth & Development Office (FCDO)
Deputy Permanent Representative for Global Health and UK Representative to the Global Health Boards | Friends of Lusaka Agenda
United Kingdom
Sania Nishtar
Gavi, the Vaccine Alliance
CEO
Switzerland
Barbara Schedler Fischer
Federal Office of Public Health (FOPH)
Ambassador for Global Health
Switzerland
Priya Basu
The Pandemic Fund
Executive Head
United States of America
Kieran Daly
Gates Foundation
Global Health Agencies and Funds | Director
United States of America
Ngashi Ngongo
Africa Centres for Disease Control and Prevention (Africa CDC)
Chief of Staff and Head of the Executive Office
Peter Sands
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Executive Director
Switzerland